REQUEST A DEMO
Total
USD $0.00
Search more companies

Orient Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Orient Drugs Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Orient Drugs Private Limited is a company in India, with a head office in Malappuram. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on March 14, 1997. The latest financial highlights indicate a net sales revenue drop of 2.81% in 2025. Its’ total assets recorded a growth of 12.66%.

Legal Address
2/254, Orient Tower, Vadakkemanna,Kodur P.O,
Malappuram; Kerala; Postal Code: 676504

Contact Details: Purchase the Orient Drugs Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Orient Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Orient Drugs Private Limited report to view the information.
Incorporation Date:
March 14, 1997
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Orient Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.81%
Total Operating Revenue
-1.73%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
12.66%
Total Equity
12.65%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-0.77%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?